Literature DB >> 10802972

Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder.

B J Coffey1, J Biederman, D A Geller, T J Spencer, G S Kim, C A Bellordre, J A Frazier, K Cradock, M Magovcevic.   

Abstract

OBJECTIVE: To examine whether tic severity, comorbid disorders, or both are associated with illness morbidity in youths with Tourette's disorder (TD).
METHOD: Subjects were 156 consecutively referred youths (aged 5-20 years) who met DSM-III-R criteria for Tourette's disorder at a major academic medical center. All subjects were evaluated with a clinical interview by a child and adolescent psychiatrist and an assessment battery that included the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Epidemiologic version. Statistical analysis used chi 2 and multivariate logistic regression.
RESULTS: Nineteen (12%) of the 156 youths with TD required psychiatric hospitalization. Current age, TD severity, TD duration, obsessive-compulsive disorder, psychosis, major depression, bipolar disorder, panic disorder, and overanxious disorder were significant univariate predictors of psychiatric hospitalization (p < .01). While tic severity was marginally significant as a predictor of psychiatric hospitalization (p < .05), major depression (p < .016) and bipolar disorder (p < .001) were robust predictors of psychiatric hospitalization, even after statistical adjustment for collinearity and correction for all other variables assessed.
CONCLUSION: The findings indicate that comorbid mood disorders are strongly associated with illness morbidity in youths with TD, highlighting the importance of attention to comorbidity in patients with TD.

Entities:  

Mesh:

Year:  2000        PMID: 10802972     DOI: 10.1097/00004583-200005000-00008

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  10 in total

1.  Neuropsychological functioning in children with Tourette syndrome with and without attention-deficit/hyperactivity disorder.

Authors:  Denis G Sukhodolsky; Angeli Landeros-Weisenberger; Lawrence Scahill; James F Leckman; Robert T Schultz
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11       Impact factor: 8.829

2.  Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study.

Authors:  Daniel A Gorman; Nancy Thompson; Kerstin J Plessen; Mary M Robertson; James F Leckman; Bradley S Peterson
Journal:  Br J Psychiatry       Date:  2010-07       Impact factor: 9.319

Review 3.  Cognitive-behavioral therapy for childhood repetitive behavior disorders: tic disorders and trichotillomania.

Authors:  Christopher A Flessner
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

4.  Health care needs of children with Tourette syndrome.

Authors:  Rebecca H Bitsko; Melissa Danielson; Michael King; Susanna N Visser; Lawrence Scahill; Ruth Perou
Journal:  J Child Neurol       Date:  2012-11-08       Impact factor: 1.987

5.  European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment.

Authors:  Danielle C Cath; Tammy Hedderly; Andrea G Ludolph; Jeremy S Stern; Tara Murphy; Andreas Hartmann; Virginie Czernecki; Mary May Robertson; Davide Martino; A Munchau; R Rizzo
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

6.  Developmental psychopathology of children and adolescents with Tourette syndrome--impact of ADHD.

Authors:  Veit Roessner; Andreas Becker; Tobias Banaschewski; Roger D Freeman; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

7.  A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.

Authors:  Vilma Gabbay; James S Babb; Rachel G Klein; Aviva M Panzer; Yisrael Katz; Carmen M Alonso; Eva Petkova; Jing Wang; Barbara J Coffey
Journal:  Pediatrics       Date:  2012-05-14       Impact factor: 7.124

8.  Adolescent with tourette syndrome and bipolar disorder: a case report.

Authors:  Se-Hoon Shim; Young-Joon Kwon
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

9.  Effects of comorbidity on Tourette's tic severity and quality of life.

Authors:  Hilde M Huisman-van Dijk; Suzy J M A Matthijssen; Ruben T S Stockmann; Anne V Fritz; Danielle C Cath
Journal:  Acta Neurol Scand       Date:  2019-09-17       Impact factor: 3.209

Review 10.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment.

Authors:  Kirsten R Müller-Vahl; Danielle C Cath; Natalia Szejko; Sally Robinson; Andreas Hartmann; Christos Ganos; Nanette M Debes; Liselotte Skov; Martina Haas; Renata Rizzo; Jeremy Stern; Alexander Münchau; Virginie Czernecki; Andrea Dietrich; Tara L Murphy; Davide Martino; Zsanett Tarnok; Tammy Hedderly
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-10-18       Impact factor: 4.785

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.